Table 1. Characteristics of Study Population at First Scan.
| Characteristics | N=213 |
|---|---|
| Age, mean (SD), year | 45.65 (2.51) |
| Race, n (%) | |
| Black | 64 (30.05) |
| Caucasian | 149 (69.95) |
| Education, n (%) | |
| <= High school | 51 (23.94) |
| Some college/college | 109 (51.17) |
| Post graduate | 53 (24.88) |
| Smoker, n (%) | |
| No | 176 (83.41) |
| Yes | 35 (16.59) |
| Menopause status, n (%) | |
| Premenopausal | 112 (52.58) |
| Early peri-menopausal | 90 (42.25) |
| Late peri-menopausal | 4 (1.88) |
| Postmenopausal | 7 (3.29) |
| BMI, mean (SD), kg/m2 | 28.23 (6.49) |
| SBP, mean (SD), mmHg | 113.27 (16.01) |
| HDL, mean (SD), mg/dL | 55.25 (11.96) |
| apoA, mean (SD) | 148.44(23.69) |
| LDL, mean (SD), mg/dL | 120.78 (29.51) |
| Triglycerides, median (Q1, Q3), mg/dL | 90.00 (68.00, 123.00) |
| HOMA index, median (Q1, Q3) | 1.72 (1.27, 2.56) |
| hs-CRP, median (Q1, Q3) | 1.60 (0.80,4.20) |
| Current use of CVD medications,a n (%) | 16 (7.51) |
| cIMT, median (Q1, Q3), mm | 0.67 (0.62, 0.71) |
| cAD, mean (SD), mm | 6.73(0.59) |
| Presence of cPlaque, n (%) | 27(12.68) |
a
CVD medications: Current use of anti-hypertensive and heart medications